5-Ethyl-6-methyl-2-(methylamino)-3,4-dihydropyrimidin-4-one

Catalog No.: 
ACGXBV335
CAS No.: 
1185143-22-9
Molecular Formula: 
C8H13N3O
Molecular Weight: 
167.21
5-Ethyl-6-methyl-2-(methylamino)-3,4-dihydropyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$987.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Ethyl-6-methyl-2-(methylamino)-3,4-dihydropyrimidin-4-one
IUPAC Name5-ethyl-6-methyl-2-(methylamino)pyrimidin-4(3H)-one
MDL No.MFCD14607563
Molecular FormulaC8H13N3O
Molecular Weight167.21
SMILESO=C1NC(NC)=NC(C)=C1CC
InChI KeyQZYJJFVDJOMOBA-UHFFFAOYSA-N
Synonym4(3H)-Pyrimidinone, 5-ethyl-6-methyl-2-(methylamino)-
CAS No.1185143-22-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACGXBV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACGXBV335 route product structure diagram
    ACGXBV3351185143-22-9
Inquiry

2. ACGXBV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBOXP417 route compound structure diagram
    ACBOXP41721770-81-0In Stock
  4. Then
  5. ACGXBV335 route product structure diagram
    ACGXBV3351185143-22-9
Inquiry

3. ACGXBV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACGXBV335 route product structure diagram
    ACGXBV3351185143-22-9
Inquiry

Comments (0)